For citations:

Papapoulos S., Man Z., Mellstrom D., Radominski S., Reginster J., Resch H., Roman J., Roux S., Cummings S., Bone H., Chapurlar R., Brandi M., Brown J., Czerwinski E., Daizadeh N., Grauer A., Krieg M., Libanati S. Five-year denosumab treatment of postmenopausalwomen with osteoporosis: results of the first twoyears of the freedom trial extension. Osteoporosis and Bone Diseases. 2011;14(1):40-40. (In Russ.) https://doi.org/10.14341/osteo2011140-40